Synthetic Oligodeoxynucleotides Containing Suppressive TTAGGG Motifs Inhibit AIM2 Inflammasome Activation
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Synthetic oligodeoxynucleotides (ODNs) comprised of the immunosuppressive motif TTAGGG block TLR9 signaling, prevent STAT1 and STAT4 phosphorylation and attenuate a variety of inflammatory responses in vivo. In this study, we demonstrate that such suppressive ODN abrogate activation of cytosolic nucleic acid–sensing pathways. Pretreatment of dendritic cells and macrophages with the suppressive ODN-A151 abrogated type I IFN, TNF-α, and ISG induction in response to cytosolic dsDNA. In addition, A151 abrogated caspase-1–dependent IL-1β and IL-18 maturation in dendritic cells stimulated with dsDNA and murine CMV. Inhibition was dependent on A151’s phosphorothioate backbone, whereas substitution of the guanosine residues for adenosine negatively affected potency. A151 mediates these effects by binding to AIM2 in a manner that is competitive with immune-stimulatory DNA and as a consequence prevents AIM2 inflammasome complex formation. Collectively, these findings reveal a new route by which suppressive ODNs modulate the immune system and unveil novel applications for suppressive ODNs in the treatment of infectious and autoimmune diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“TTAGGG repeat commonly found in mammalian telomeres has been shown to be able to inhibit TLR9 signaling and downstream immune activation (156, 157).”
From A versatile toolkit for overcoming AAV immunity (2022) · cites this paper as [156]
Citations
Cites
A Toll-like receptor recognizes bacterial DNA
Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., et al. (2000) · Nature · doi:10.1038/35047123 · Cited by 6,491 · cited 8×
“Synthetic oligodeoxynucleotides (ODNs) comprised of the immunosuppressive motif TTAGGG block TLR9 signaling, prevent STAT1 and STAT4 phosphorylation and attenuate a variety of inflammatory responses in vivo.”
BackgroundInfluentialCryopyrin activates the inflammasome in response to toxins and ATP
Mariathasan, S., Weiss, D. S., Newton, K., McBride, J., O'Rourke, K., Roose-Girma, M., Lee, W. P., Weinrauch, Y., Monack, D. M., & Dixit, V. M. (2006) · Nature · doi:10.1038/nature04515 · Cited by 3,080
AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC
Hornung, V., Ablasser, A., Charrel-Dennis, M., Bauernfeind, F., Horvath, G., Caffrey, D. R., Latz, E., & Fitzgerald, K. A. (2009) · Nature · doi:10.1038/nature07725 · Cited by 2,627 · cited 3×
“Bone marrow–derived macrophages (BMDM) and bone marrow–derived dendritic cells (BMDC) were generated as described (6, 28).”
BackgroundMethodSelf-citationHornung, V., Rothenfusser, S., Britsch, S., Krug, A., Jahrsdörfer, B., Giese, T., Endres, S., & Hartmann, G. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.9.4531 · Cited by 1,935 · cited 1×
“Moreover, HEK293T are devoid of endogenous TLR expression, allowing us to examine the effects of sup ODN A151 in a system free of TLR signaling (35).”
BackgroundAIM2 activates the inflammasome and cell death in response to cytoplasmic DNA
Fernandes-Alnemri, T., Yu, J.-W., Datta, P., Wu, J., & Alnemri, E. S. (2009) · Nature · doi:10.1038/nature07710 · Cited by 1,831 · cited 1×
“In addition, our laboratory and others (5, 6, 13, 14) have recently reported that the AIM2 protein directly binds to cytosolic bacterial and viral dsDNA, leading to the formation of an AIM2 inflammasome complex.”
BackgroundDAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response
Takaoka, A., Wang, Z., Choi, M. K., Yanai, H., Negishi, H., Ban, T., Lu, Y., Miyagishi, M., Kodama, T., Honda, K., et al. (2007) · Nature · doi:10.1038/nature06013 · Cited by 1,715
IFI16 is an innate immune sensor for intracellular DNA
Unterholzner, L., Keating, S. E., Baran, M., Horan, K. A., Jensen, S. B., Sharma, S., Sirois, C. M., Jin, T., Latz, E., Xiao, T. S., et al. (2010) · Nature Immunology · doi:10.1038/ni.1932 · Cited by 1,643 · cited 5×
“Unterholzner et al. (10) have previously demonstrated that IFN-b induction and NF-kB activation in response to cytosolic DNA or HSV-1 infection is dependent on IFI16.”
BackgroundInfluentialSelf-citationThe AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses
Rathinam, V. A. K., Jiang, Z., Waggoner, S. N., Sharma, S., Cole, L. E., Waggoner, L., Vanaja, S. K., Monks, B. G., Ganesan, S., Latz, E., et al. (2010) · Nature Immunology · doi:10.1038/ni.1864 · Cited by 1,331
Self-citationRNA Polymerase III Detects Cytosolic DNA and Induces Type I Interferons through the RIG-I Pathway
Chiu, Y.-H., MacMillan, J. B., & Chen, Z. J. (2009) · Cell · doi:10.1016/j.cell.2009.06.015 · Cited by 1,174
Bürckstümmer, T., Baumann, C., Blüml, S., Dixit, E., Dürnberger, G., Jahn, H., Planyavsky, M., Bilban, M., Colinge, J., Bennett, K. L., et al. (2009) · Nature Immunology · doi:10.1038/ni.1702 · Cited by 1,091 · cited 1×
“In addition, our laboratory and others (5, 6, 13, 14) have recently reported that the AIM2 protein directly binds to cytosolic bacterial and viral dsDNA, leading to the formation of an AIM2 inflammasome complex.”
Background
Cited by
The cGAS–STING pathway as a therapeutic target in inflammatory diseases
Decout, A., Katz, J. D., Venkatraman, S., & Ablasser, A. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-021-00524-z · Cited by 2,309
Inflammasome activation and regulation: toward a better understanding of complex mechanisms
Zheng, D., Liwinski, T., & Elinav, E. (2020) · Cell Discovery · doi:10.1038/s41421-020-0167-x · Cited by 1,026
Siu, K., Yuen, K., Castano‐Rodriguez, C., Ye, Z., Yeung, M., Fung, S., Yuan, S., Chan, C., Yuen, K., Enjuanes, L., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201802418r · Cited by 502
“To investigate the role of AIM2 in SARS-CoV–induced inflammasome activation, a specific oligonucleotide inhibitor of AIM2 known as A151 (50) was employed.”
MethodInfluentialMan, S. M., Karki, R., & Kanneganti, T. (2016) · European Journal of Immunology · doi:10.1002/eji.201545839 · Cited by 354
The AIM 2 inflammasome: Sensor of pathogens and cellular perturbations
Lugrin, J., & Martinon, F. (2018) · Immunological Reviews · doi:10.1111/imr.12618 · Cited by 333
Role of AIM2 inflammasome in inflammatory diseases, cancer and infection
Sharma, B. R., Karki, R., & Kanneganti, T. (2019) · European Journal of Immunology · doi:10.1002/eji.201848070 · Cited by 294
Sterile inflammation and pregnancy complications: a review
Nadeau-Vallée, M., Obari, D., Palacios, J., Brien, M.-È., Duval, C., Chemtob, S., & Girard, S. (2016) · Reproduction · doi:10.1530/rep-16-0453 · Cited by 275
Inhibition of double‐strand DNA‐sensing cGAS ameliorates brain injury after ischemic stroke
Li, Q., Cao, Y., Dang, C., Han, B., Han, R., Ma, H., Hao, J., & Wang, L. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.201911002 · Cited by 273
“…without sup ODN A151 (1 h pretreatment; 3 lM); the cells were transfected with synthetic DNA analogue poly(dA:dT) (Invivogen) using Lipofectamine 2000 (Invitrogen), according to the manufacturer’s protocol, in OptiMEM (Gibco) for 6 h (Kaminski et al, 2013; Dick et al, 2016; Steinhagen et al, 2018).”
BackgroundMethodDesigning DNA nanodevices for compatibility with the immune system of higher organisms
Surana, S., Shenoy, A. R., & Krishnan, Y. (2015) · Nature Nanotechnology · doi:10.1038/nnano.2015.180 · Cited by 243
Overcoming innate immune barriers that impede AAV gene therapy vectors
Muhuri, M., Maeda, Y., Ma, H., Ram, S., Fitzgerald, K. A., Tai, P. W. L., & Gao, G. (2021) · Journal of Clinical Investigation · doi:10.1172/jci143780 · Cited by 212
“• The ability of TTAGGG motifs to inhibit cGAS and AIM2 inflammasome activation has also been documented (86, 87).”
BackgroundSelf-citationInflammasome components as new therapeutic targets in inflammatory disease
Coll, R. C., & Schroder, K. (2024) · Nature reviews. Immunology · doi:10.1038/s41577-024-01075-9 · Cited by 186
“79).”
Immunogenicity of Recombinant Adeno-Associated Virus (AAV) Vectors for Gene Transfer
Arjomandnejad, M., Dasgupta, I., Flotte, T. R., & Keeler, A. M. (2023) · BioDrugs · doi:10.1007/s40259-023-00585-7 · Cited by 159
Zhou, C., & Fang, J. (2019) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2019.05.001 · Cited by 159
Inflammasomes, the eye and anti-inflammasome therapy
Yerramothu, P., Vijay, A. K., & Willcox, M. D. P. (2017) · Eye · doi:10.1038/eye.2017.241 · Cited by 157
Innate Sensing of DNA Virus Genomes
Ma, Z., Ni, G., & Damania, B. (2018) · Annual Review of Virology · doi:10.1146/annurev-virology-092917-043244 · Cited by 136
Federico, S., Pozzetti, L., Papa, A., Carullo, G., Gemma, S., Butini, S., Campiani, G., & Relitti, N. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01049 · Cited by 125
Steinhagen, F., Zillinger, T., Peukert, K., Fox, M., Thudium, M., Barchet, W., Putensen, C., Klinman, D., Latz, E., & Bode, C. (2018) · European Journal of Immunology · doi:10.1002/eji.201747338 · Cited by 112
Self-citationPatel, M. N., Tiwari, S., Wang, Y., O’Neill, S., Wu, J., Omo‐Lamai, S., Espy, C. L., Chase, L. S., Majumder, A., Hoffman, E. T., et al. (2025) · Nature Biotechnology · doi:10.1038/s41587-025-02556-5 · Cited by 119
Dubey, S. R., Turnbull, C., Pandey, A., Zhao, A., Kurera, M., Al-Zidan, R. N., Shen, C. X., Gautam, M., Mahajan, S., Jadhav, P. S., et al. (2025) · Cellular and Molecular Immunology · doi:10.1038/s41423-025-01354-y · Cited by 113
Targeting immunometabolism against acute lung injury
Ning, L., Shishi, Z., Wang, B., & Huiqing, L. (2023) · Clinical Immunology · doi:10.1016/j.clim.2023.109289 · Cited by 108
Immunobiology and structural biology of AIM2 inflammasome
Wang, B., Bhattacharya, M., Roy, S., Tian, Y., & Yin, Q. (2020) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2020.100869 · Cited by 105
“Interestingly, telomeric DNA sequences such as TTAGGG repeat inhibit AIM2 inflammasome activation, presumably by competing with dsDNA for AIM2 binding and sequestering AIM2 in an unproductive form (Kaminski et al., 2013).”
BackgroundByrd, A. K., Zybailov, B. L., Maddukuri, L., Gao, J., Marecki, J. C., Jaiswal, M., Bell, M. R., Griffin, W. C., Reed, M. R., Chib, S., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.718478 · Cited by 99
“Oligonucleotides composed of telomeric sequences (TTAGGG) have been introduced into cells, resulting in the suppression of a variety of inflammatory responses including blocking of Toll-like receptor 9 (3).”
BackgroundImmune-Complexed Adenovirus Induce AIM2-Mediated Pyroptosis in Human Dendritic Cells
Eichholz, K., Bru, T., Tran, T. T. P., Fernandes, P., Welles, H. C., Mennechet, F. J. D., Manel, N., Alves, P. M., Perreau, M., & Kremer, E. J. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005871 · Cited by 97
“Importantly, pre-incubation with ODN A151 also rescuedMoDCs from loss of cell membrane integrity when cells are transfected with plasmid DNA (S5 Fig).”
BackgroundInfluentialInflammasome: structure, biological functions, and therapeutic targets
Dai, Y., Zhou, J., & Shi, C. (2023) · MedComm · doi:10.1002/mco2.391 · Cited by 98
NLRP3 inflammasome as a sensor of micro- and nanoplastics immunotoxicity
Alijagić, A., Hedbrant, A., Persson, A., Larsson, M., Engwall, M., & Särndahl, E. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1178434 · Cited by 85
“AIM2 responds to pathogenassociated double stranded DNA and is mainly expressed in hematopoietic cells (37, 38).”
BackgroundWu, X., Yu, N., Ye, Z., Gu, Y., Zhang, C., Chen, M., & Wang, K. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06140-0 · Cited by 80
Clonal hematopoiesis and atherosclerosis
Oren, O., Small, A. M., & Libby, P. (2024) · Journal of Clinical Investigation · doi:10.1172/jci180066 · Cited by 82
“Synthetic oligonucleotides that antagonize AIM2 are currently under development (54).”
Negative regulation of the inflammasome: keeping inflammation under control
Pedraza‐Alva, G., Pérez‐Martínez, L., Valdez‐Hernández, L., Meza‐Sosa, K. F., & Ando‐Kuri, M. (2015) · Immunological Reviews · doi:10.1111/imr.12294 · Cited by 85
“Accordingly, suppressive oligonucleotides reduced IL-1b and IL-18 production in dendritic cells infected with cytomegalovirus (22).”
BackgroundInfluentialThe emerging role of human PYHIN proteins in innate immunity: Implications for health and disease
Connolly, D. J., & Bowie, A. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.08.031 · Cited by 82
“For example ODN-A151 has been shown to inhibit dsDNA induced type I IFN, TNFa, ISG induction and caspase 1 dependent IL-1b and IL-18 maturation by binding to AIM2.”
BackgroundA versatile toolkit for overcoming AAV immunity
Li, X., Wei, X., Lin, J., & Ou, L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.991832 · Cited by 57
“TTAGGG repeat commonly found in mammalian telomeres has been shown to be able to inhibit TLR9 signaling and downstream immune activation (156, 157).”
BackgroundCamões, S. P., Bulut, O., Yazar, V., Gaspar, M. M., Simões, S., Ferreira, R., Vitorino, R., Santos, J. M., Gursel, I., & Miranda, J. P. (2022) · Journal of Advanced Research · doi:10.1016/j.jare.2022.01.013 · Cited by 55
Regulation and inhibition of the DNA sensor cGAS
Hertzog, J., & Rehwinkel, J. (2020) · EMBO Reports · doi:10.15252/embr.202051345 · Cited by 55
“However, the specificity of this supODN should be tested in future studies, given that supODNs have broad immunosuppressive functions and also inhibit TLRs, inflammasome activation and STAT signalling (Gursel et al , 2003; Kaminski et al , 2013; Bayik et al , 2016).”
DNA-sensing pathways in health, autoinflammatory and autoimmune diseases
Dong, M., & Fitzgerald, K. A. (2024) · Nature Immunology · doi:10.1038/s41590-024-01966-y · Cited by 53
Self-citationLozano‐Ruiz, B., Bachiller, V., García‐Martinez, I., Zapater, P., Gómez‐Hurtado, I., Moratalla, A., Giménez, P., Bellot, P., Francés, R., Such, J. M., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.08.027 · Cited by 52
“To confirm that this response is mediated by AIM2, we used a suppressive oligodeoxynucleotide (ODN) that functions as a competitive inhibitor of AIM2 [17].”
Itagaki, K., Riça, I. G., Konečná, B., Kim, H. I., Park, J. B., Kaczmarek, E., & Hauser, C. J. (2021) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0052 · Cited by 50
“We further showed that this NET formation was TLR9-dependent, as it was completely blocked by the inhibitory ODN TTAGGG that blocks TLR9 signaling (5, 52, 56).”
Inhibitory targeting cGAS-STING-TBK1 axis: Emerging strategies for autoimmune diseases therapy
Zhang, M., Zou, Y., Zhou, X., & Zhou, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.954129 · Cited by 50
Green, J., El‐Sharkawy, L. Y., Roth, S., Zhu, J., Cao, J., Leach, A. G., Liesz, A., Freeman, S., & Brough, D. (2023) · iScience · doi:10.1016/j.isci.2023.106758 · Cited by 48
Cytosolic nucleic acid sensing as driver of critical illness: mechanisms and advances in therapy
Chen, Z., Behrendt, R., Wild, L., Schlee, M., & Bode, C. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02174-2 · Cited by 50
Self-citationThe Emerging Relevance of AIM2 in Liver Disease
Lozano‐Ruiz, B., & González-Navajas, J. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186535 · Cited by 45
“This ODN, comprised of four repeats of the motif TTAGGG, binds to AIM2 and functions as a competitive inhibitor of the dsDNA–AIM2 interaction, consequently blocking inflammasome assembly [37].”
BackgroundThe role of circulating cell-free DNA as an inflammatory mediator after stroke
Roth, S., Wernsdorf, S. R., & Liesz, A. (2023) · Seminars in Immunopathology · doi:10.1007/s00281-023-00993-5 · Cited by 45
“Other DNA binding site inhibitors are synthetic oligonucleotides such as A151 caring a hexanucleotide motif suppressing DNA sensor signaling [131].”
BackgroundInfluentialAbsent in Melanoma 2 proteins in SLE
Choubey, D., & Panchanathan, R. (2017) · Clinical Immunology · doi:10.1016/j.clim.2016.12.011 · Cited by 42
Maimaiti, M., Li, C., Cheng, M., Zhong, Z., Hu, J., Yang, L., Zhang, L., Hong, Z., Song, J., Pan, M., et al. (2024) · Med · doi:10.1016/j.medj.2024.03.018 · Cited by 45
Dawson, R., Deswaerte, V., West, A. C., Tang, K., West, A. J., Balic, J. J., Gearing, L. J., Saad, M. I., Yu, L., Wu, Y., et al. (2021) · Gut · doi:10.1136/gutjnl-2020-323916 · Cited by 42
Self-citationHematopoiesis under telomere attrition at the single-cell resolution
Thongon, N., Ma, F., Santoni, A., Marchesini, M., Fiorini, E., Rose, A. M., Ademà, V., Gañán‐Gómez, I., Groarke, E. M., Gutierrez‐Rodrigues, F., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-27206-7 · Cited by 41
Rational design of antisense oligonucleotides modulating the activity of TLR7/8 agonists
Alharbi, A. S., Garcin, A., Lennox, K. A., Pradeloux, S., Wong, C., Straub, S., Valentin, R., Pépin, G., Li, H., Nold, M. F., et al. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa523 · Cited by 44
“Further studies are therefore needed to define the structural determinants of therapeutic PS-oligonucleotides governing these immune inhibitory effects, to avoid the risk of promoting intercurrent pathogenic infections in patients.”
InfluentialStructure, mechanism and therapeutic utility of immunosuppressive oligonucleotides
Bayık, D., Gürsel, İ., & Klinman, D. M. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2015.11.010 · Cited by 44
Self-citationSequence-dependent inhibition of cGAS and TLR9 DNA sensing by 2′- O -methyl gapmer oligonucleotides
Valentin, R., Wong, C., Alharbi, A. S., Pradeloux, S., Morros, M. P., Lennox, K. A., Ellyard, J. I., Garcin, A., Ullah, T. R., Kusuma, G. D., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab451 · Cited by 40
“There is, however, prior evidence that PS-ODN can inhibit AIM2 (17) and that 2′OMe moieties can modulate RIG-I sensing (11), indicating that the immunosuppressive effects of ASOs are even broader than considered here.”
BackgroundThe emerging roles of absent in melanoma 2 (AIM2) inflammasome in central nervous system disorders
Li, Y.-K., Chen, J., & Wang, F. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105122 · Cited by 39
Zhao, J., Mou, Y., Bernstock, J. D., Klimanis, D., Wang, S., Spatz, M., Maric, D., Johnson, K. R., Klinman, D. M., Li, X., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0140772 · Cited by 39
“It is interesting to note that by supplementing extracellular poly(dA:dT) or by a DNA virus infection, Kaminski and colleagues showed that A151 binds to AIM2 and thereby competes for the binding of immune-stimulatory DNA [70].”
BackgroundSelf-citationNew insights into nucleic acid sensor AIM2: The potential benefit in targeted therapy for cancer
Cui, J.-Z., Chew, Z. H., & Lim, L. H. K. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107079 · Cited by 37
Immune aging and infectious diseases
Chen, R., Zou, J., Chen, J., Wang, L., Kang, R., & Tang, D. (2024) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003410 · Cited by 39
“[ 32 ] The balance between the pro-inflammatory and anti-inflammatory effects of telomeric sequences may be influenced by the availability of complementary RNA sequences, modulating the formation of RNA hybrids and regulating the activation of both cGAS and TLR9.”
Codon-Optimized P1A-Encoding DNA Vaccine: Toward a Therapeutic Vaccination against P815 Mastocytoma
Lopes, A., Vanvarenberg, K., Véronique Préat, A., & Vandermeulen, G. (2017) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2017.07.011 · Cited by 37
“Molecular Thera innate immune system activation.(43) The transgene in the CO50 construct did not contain some of the immunoinhibitory motifs (e.”
BackgroundBaruah, P., Bullenkamp, J., Wilson, P., Lee, M., Kaski, J. C., & Dumitriu, I. E. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01644 · Cited by 34
“For this purpose we used the oligonucleotide ODN TTAGGG (A151), which is a specific antagonist of human TLR9 (37, 38).”
MethodChhunchha, B., Kubo, E., Lehri, D., & Singh, D. P. (2025) · Cells · doi:10.3390/cells14130994 · Cited by 35
“Interestingly, inhibitory ssDNA (oligodeoxynucleotide) [116] containing four repeats of TTAGGG has been found to inhibit AIM2 signaling by interfering with activating DNA ligands [115]; however the regulation of this process requires validation in vivo.”
The role of extracellular DNA in COVID-19: Clues from inflamm-aging
Storci, G., Bonifazi, F., Garagnani, P., Olivieri, F., & Bonafè, M. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101234 · Cited by 32
Exploiting the telomere machinery to put the brakes on inflamm-aging
Bonafè, M., Sabbatinelli, J., & Olivieri, F. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101027 · Cited by 31
Absent in melanoma 2 (AIM2) in rheumatoid arthritis: novel molecular insights and implications
Zhao, J., Guo, S., Schrodi, S. J., & He, D. (2022) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-022-00402-z · Cited by 29
Interrupting cyclic dinucleotide-cGAS–STING axis with small molecules
Sintim, H. O., Mikek, C. G., Wang, M., & Sooreshjani, M. A. (2019) · MedChemComm · doi:10.1039/c8md00555a · Cited by 30
Kopfnagel, V., Dreyer, S., Baumert, K., Stark, M., Harder, J., Hofmann, K., Kleine, M., Buch, A., Sodeik, B., & Werfel, T. (2020) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2019.09.029 · Cited by 28
Activation and Immune Regulation Mechanisms of PYHIN Family During Microbial Infection
Fan, X., Jiao, L., & Jin, T. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.809412 · Cited by 29
“…2010; Rathinam et al., 2010; Sauer et al., 2010; Warren et al., 2010; Wu et al., 2010; Ge et al., 2012), Streptococcus pneumoniae (Fang et al., 2011), Mycobacterium tuberculosis (Saiga et al., 2012), Staphylococcus aureus (Hanamsagar et al., 2014), and Aspergillus fumigatus (Karki et al., 2015).”
BackgroundRuwanpura, S. M., McLeod, L., Dousha, L. F., Seow, H. J., West, A. C., West, A. J., Weng, T., Alanazi, M. A., MacDonald, M., King, P. T., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2201494119 · Cited by 27
Self-citationWang, Y., Xu, G., Wang, Z., Li, R., Zhan, X., Liu, H., Qin, Q., Li, W., Wang, X., Zhang, M., et al. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2020.107352 · Cited by 26
IFI16-STING-NF-κB signaling controls exogenous mitochondrion-induced endothelial activation
Li, S., Xu, H., Song, M., Shaw, B. I., Li, Q.-J., & Kirk, A. D. (2022) · American Journal of Transplantation · doi:10.1111/ajt.17034 · Cited by 19
AIM2 inflammasome activation benefits the therapeutic effect of BCG in bladder carcinoma
Zhou, H., Zhang, L., Luo, W., Hong, H., Tang, D., Zhou, D., Zhou, L., & Li, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1050774 · Cited by 21
“acid-sensing pathways and prevent AIM2 inflammasome complex formation (Kaminski et al., 2013).”
BackgroundThe role of NLRP3 inflammasome in psychotropic drug-induced hepatotoxicity
Mu, W., Xu, G., Wei, Z., Wang, Z., Qin, Q., Li, L., Ren, L., Liu, T., Fang, Z., Yang, Y., et al. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-01109-y · Cited by 19
“In contrast, AIM2 inflammasome did not appear to be essential for fluoxetine signaling, because the administration of synthetic oligodeoxynucleotide (ODN) [28], a selective and potent blocker of AIM2, completely blocked poly(dA:dT)-triggered AIM2 inflammasome activation rather than fluoxetine (Fig.”
BackgroundInflammasome-independent functions of AIM2
Zhao, J., Miller-Little, W. A., & Li, X. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20210273 · Cited by 16
Patel, B., Zhou, Y., Babcock, R. L., Ma, F., Zal, M. A., Kumar, D., Medik, Y. B., Kahn, L. M., Pineda, J. E., Park, E. M., et al. (2024) · Leukemia · doi:10.1038/s41375-024-02218-6 · Cited by 15
The roles of AIM2 in neurodegenerative diseases: insights and therapeutic implications
Yang, K., Wang, X. L., Pan, H., Wang, X., Hu, Y., Yao, Y.-H., Zhao, X., & Sun, T. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1441385 · Cited by 20
HSV-2 Cellular Programming Enables Productive HIV Infection in Dendritic Cells
Crisci, E., Svanberg, C., Ellegård, R., Khalid, M., Hellblom, J., Okuyama, K., Bhattacharya, P., Nyström, S. N., Shankar, E. M., Eriksson, K., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02889 · Cited by 18
“Intracellular delivery of cGAMP, Poly dA:dT, HSV-60 Naked DNA, A151 oligonucleotide, UL83 protein, and E7 protein was achieved using a commercial DOTAP system (SIGMA).”
BackgroundMethodInfluentialTricyclic antidepressants induce liver inflammation by targeting NLRP3 inflammasome activation
Mu, W., Xu, G., Wang, Z., Li, Q., Sun, S., Qin, Q., Li, Z., Shi, W., Dai, W., Zhan, X., et al. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01128-x · Cited by 15
“To identify which type of inflammasome was activated by nortriptyline, LPS-primed BMDMs were treated with MCC950 (a selective NLRP3 inhibitor) [38] and specific AIM2 inhibitor ODN [39] 1 h before nortriptyline stimulation.”
MethodInfluentialChoubey, D., & Panchanathan, R. (2019) · Cytokine · doi:10.1016/j.cyto.2019.03.008 · Cited by 15
Karakasis, P., Theofilis, P., Lefkou, E. E., Antoniadis, A. P., Patoulias, D., Korantzopoulos, P. G., & Fragakis, N. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26062739 · Cited by 14
“Similarly, inhibition of the AIM2 inflammasome offers potential for AF risk reduction, with preliminary studies in murine models demonstrating significant decreases in inflammatory burden following treatment with AIM2-antagonizing synthetic oligonucleotides [98].”
A short history of the atrial NLRP3 inflammasome and its distinct role in atrial fibrillation
Poppenborg, T., Saljic, A., Bruns, F., Abu-Taha, I., Dobrev, D., & Fender, A. C. (2025) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2025.02.011 · Cited by 16
Targeting innate immune sensors for therapeutic strategies in infectious diseases
Shin, S., Choi, Y. K., & Lee, S. (2025) · The Journal of Microbiology · doi:10.71150/jm.2503009 · Cited by 14
“ODN A151 can inhibit AIM2 inflammasome assembly, block caspase-1 activation, and prevent IL-1β maturation in antigen-presenting cells (Kaminski et al., 2013).”
Cytoplasmic DNA and AIM2 inflammasome in RA: where they come from and where they go?
Xu, C., Jing, W., Liu, C., Yuan, B., Zhang, X., Liu, L., Zhang, F., Chen, P., Liu, Q., Wang, H., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1343325 · Cited by 12
A Dual TLR7/TLR9 Inhibitor HJ901 Inhibits ABC-DLBCL Expressing the MyD88 L265P Mutation
An, B., Zhu, S., Li, T., Wu, J., Zang, G., Lv, X., Qiao, Y., Huang, J., Shao, Y., Cui, J., et al. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00262 · Cited by 12
Suppressive oligodeoxynucleotides reduce lung cancer susceptibility in mice with silicosis
Bode, C., Kinjo, T., Alvord, W. G., & Klinman, D. M. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu005 · Cited by 12
Self-citationOligonucleotide-Based Drug Development: Considerations for Clinical Pharmacology and Immunogenicity
Wang, J., Lon, H., Lee, S., Burckart, G. J., & Pisetsky, D. S. (2015) · Therapeutic Innovation & Regulatory Science · doi:10.1177/2168479015592195 · Cited by 12
“As a result, DNA can exist in stimulatory, inhibitory, or inert forms.(35,36) Protein binding can also influence the immunologic profile of DNA by changing the cellular uptake and trafficking.”
BackgroundBeck, S., Buhimschi, I. A., Summerfield, T. L. S., Ackerman, W. E., Guzeloglu‐Kayisli, O., Kayisli, U. A., Zhao, G., Schatz, F., Lockwood, C. J., & Buhimschi, C. S. (2019) · American Journal of Reproductive Immunology · doi:10.1111/aji.13100 · Cited by 12
Yazar, V., Kılıç, G., Bulut, O. P., Yildirim, T. C., Yağcı, F. C., Aykut, G., Klinman, D. M., Gürsel, M., & Gürsel, İ. (2019) · International Immunology · doi:10.1093/intimm/dxz059 · Cited by 12
Self-citationZhong, M., Zhang, L., Wang, Z., Dang, W., Chen, H., Li, T., Liu, Y., & Tan, W. (2025) · Nano Letters · doi:10.1021/acs.nanolett.4c05340 · Cited by 11
Scheiermann, J., & Klinman, D. M. (2016) · Journal of Thoracic Disease · doi:10.21037/jtd.2016.08.18 · Cited by 9
“Previous studies showed that Sup ODN A151 inhibited the production of pro‑inflammatory cytokines and chemokines by interfering with the phosphorylation of STATs 1, 3, 4 and AIM2 (19‑24).”
BackgroundSelf-citationInflammasomes and idiopathic inflammatory myopathies
Sun, R., Chu, J., & Li, P. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1449969 · Cited by 8
Bode, C., Wang, J., & Klinman, D. M. (2014) · International Immunopharmacology · doi:10.1016/j.intimp.2014.09.027 · Cited by 10
Self-citationWang, H., Su, Y., Chen, D., Li, Q., Shi, S., Huang, X., Fang, M., & Yang, M. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1119431 · Cited by 7
Shi, W. M., Gao, Y., Yang, H., Li, H., Liu, T., Zhao, J., Wei, Z., Lin, L., Huang, Y., Guo, Y., et al. (2024) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2024.111133 · Cited by 7
Taking AIM at Influenza: The Role of the AIM2 Inflammasome
Xu, D. W., & Tate, M. D. (2024) · Viruses · doi:10.3390/v16101535 · Cited by 6
“ODN A151, a synthetic suppressive oligodeoxynucleotide, antagonises cytoplasmic dsDNA by competitively binding to AIM2 [102].”
BackgroundHow studies on inflamm-aging may help to understand and combat COVID-19 pandemic.Preprint
Storci, G., Bonifazi, F., Garagnani, P., Olivieri, F., & Bonafè, M. (2020) · Preprints.org · doi:10.20944/preprints202004.0158.v1 · Cited by 7
Cellular signaling, molecular activation, and regulation of the AIM2 inflammasome
Lozano‐Ruiz, B., Tzoumpa, A., Picó, J., Huang, Y., & González-Navajas, J. M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91802-2.00027-x · Cited by 5
Poxvirus dsDNA genomes differentially activate AIM2 or NLRP3 inflammasomes in human primary cells
Tesfamariam, Y. M., Christensen, M. H., Diehl, S., Klein, T., Lingnau, J., Normann, S., Hagelauer, E., Herbert, M., Reimer, S., Joshi, R., et al. (2026) · The EMBO Journal · doi:10.1038/s44318-025-00690-z · Cited by 5
“A commercially available suppressive 24-mer oligodeoxynucleotide (ODN) TTAGGG, also known as A151, has been reported to inhibit dsDNA sensing by AIM2, cGAS and TLR9, but is not speci fi c for AIM2 (Kaminski et al, 2013; Steinhagen et al, 2018; Araie et al, 2018).”
Duan, W., Li, Y., Xie, Q., Zheng, Z., Yang, J., Yu, J., & Jian, Q. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116951 · Cited by 4
Golenkina, E. A., Viryasova, G. M., Dolinnaya, N. G., Bannikova, V. A., Gaponova, T. V., Romanova, Y. M., & Sud’ina, G. F. (2020) · Biomolecules · doi:10.3390/biom10020249 · Cited by 4
“The telomeric repeats in synthetic ODNs can also prevent STAT1 and STAT4 phosphorylation and attenuate a variety of inflammatory responses in vivo through blocking TLR9 signaling way [18,19].”
BackgroundTargeting pattern recognition receptors for cancer therapy: Mechanisms and strategies
Ouyang, D., Chen, R., Xie, H., Yang, X., Li, Q., & Chen, J. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.09.007 · Cited by 3
Traditional approaches and recent tools for studying inflammasome activity
Almeida-da-Silva, C. L. C., Moreira-Souza, A. C. A., & Ojcius, D. M. (2024) · Journal of Immunological Methods · doi:10.1016/j.jim.2024.113744 · Cited by 3
Mitochondrial DNA leakage in aging: Mechanisms, pathological effects, and therapeutic horizons
Chen, Z., Wu, Q., Tian, Y., Gu, L. C. R. O. D. I., Liu, X., & Liu, J. (2026) · Genes & Diseases · doi:10.1016/j.gendis.2026.102134 · Cited by 2
Brown, K. E., Puig, M., Haile, L. A., Ireland, D. D. C., Martucci, J., & Verthelyi, D. I. (2018) · Wiley eBooks · doi:10.1002/9781119070153.ch16 · Cited by 2
rFIP-nha activates macrophages towards a pro-inflammatory phenotype via AIM2 inflammasome modulation
Liu, Y., Li, Z., Wichers, H. J., Bastiaan‐Net, S., & Hoppenbrouwers, T. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1533742 · Cited by 2
Wang, J., Yao, B., Zhang, Y., Liu, S., Liu, W., Han, Y., Shi, K., Han, W., Li, R., Cai, Z., et al. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03925-7 · Cited by 1
“Several immunosuppressive ODNs have been developed to alleviate excessive inflammation and immune activation by targeting different factors involved in immune responses [36–38].”
Yamada, H., Nagase, S., Takahashi, K., Sakoda, Y., Kida, H., & Okamoto, S. (2016) · Antiviral Research · doi:10.1016/j.antiviral.2016.02.012 · Cited by 1
“ODNs, D35 and K3, which contain a CpG motif, activate TLR9-mediated immune response (Puig et al., 2006) , while A151 comprised of the immunosuppressive motif TTAGGG blocks TLR9 signaling (Kaminski et al., 2013) .”
BackgroundYazar, V., Yilmaz, I. C., Bulbul, A., Klinman, D. M., & Gürsel, İ. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2023.02.004 · Cited by 1
Self-citation
Metadata
- Authors
- Kaminski, J. J., Schattgen, S. A., Tzeng, T.-C., Bode, C., Klinman, D. M., & Fitzgerald, K. A.
- Affiliations
- University of Massachusetts Chan Medical School (US)
- National Institutes of Health (US)
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-10-01
- Volume
- 191
- Issue
- 7
- Pages
- 3876-3883
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- PMC
- PMC3878640
- OpenAlex
- W1564784210
- Cited by
- 112
- References
- 43
- Citations by year
- 2026: 5 · 2025: 11 · 2024: 14 · 2023: 12 · 2022: 12 · 2021: 11 · 2020: 13 · 2019: 9 · 2018: 2 · 2017: 5 · 2016: 7 · 2015: 7 · 2014: 4
- FWCI
- 3.32
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- The Journal of the American Medical Association (JAMA) Network (American Medical Association) (submittedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (AI083215, R01AI093752, AI093752, R01AI083713, T32AI007349, P01AI083215, T32AI095213)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Keywords
- AIM2 inflammasome, inflammasome inhibition, cytosolic DNA sensing, TLR9 signaling, STAT1 phosphorylation, STAT4 phosphorylation, type I interferon, IL-1β maturation, caspase-1, dendritic cells, macrophages, phosphorothioate backbone, murine cytomegalovirus, immunosuppression, autoimmune disease therapy
- MeSH terms
- Animals, Anti-Inflammatory Agents, Cell Line, Cytoskeletal Proteins, Cytosol, DNA, DNA-Binding Proteins, Gene Expression Regulation, Humans, Nuclear Proteins, Oligodeoxyribonucleotides, Protein Binding, Thionucleotides, Signal Transduction, Cluster Analysis, Gene Expression Profiling, Mice, Protein Multimerization, Inflammasomes, Nucleotide Motifs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.